Xeina Drugs enables its clients to achieve a dominant position in the market place by bringing difficult to manufacturer and rare drugs to their portfolio. With increasing R&D costs and risk of product failures, there is a limitation on the new product launches a company can undertake year on year. At Xeina Drugs, we understand the need to constantly enhance the portfolio and through our extensive network and distribution channels we can add value to your portfolio.
LICENSING AND SUPPLY OF FINISHED DOSAGE PRODUCTS
We help you attain quicker reach to achieve and sustain market leadership by capitalizing on our EU /USFDA approved manufacturing network across Spain, Italy, Germany, Poland, Israel, India, Korea, Taiwan, Japan and USA. We work with flexible business models and can offer products as a finished product, Bulk product or technology transfer, as the need may be.
REGULATORY COMPLIANCE SERVICES
Our In depth regulatory understanding contributes to a smooth dossier preparation and dossier filing process. We aid in enhancing the speed of Marketing Authorizations approvals by leveraging our experience in submitting comprehensive dossiers and preempting dossier queries. We also offer project management services for countries with a high complex regulatory framework (Brazil, Mexico, Russia).
Xeina is in a strategic position to offer end to end consultancy services in the pharmaceutical spectrum, right from strategy to execution. Xeina Drugs offers consultancy services covering a wide spectrum of marketing and business areas. With its team of highly experienced industry professionals, Xeina offers consultancy services for portfolio Identification, market and product analysis and entry strategies for emerging markets. Xeina also offer services on a retainer model to become the exclusive sourcing partners for international companies who wish to have a base in India to expedite their sourcing requirements, target the special import business vertical where price and speed are of critical importance as well as to get the first right of refusal of our specialized products.
The Advantage We Offer:
- Long term sustainability in sales revenues for manufacturers looking at out – licensing their products in emerging markets through high value clients with secured payments.
- Differentiated products and first entry generics from vetted, pre - audited manufacturing sources for clients looking at in – licensing products to expand their portfolio and gain competitive advantage in their market
- Consultancy services from strategy to execution for companies looking at exponential growth and value creation